AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
EVALUATION OF BIOMARKERS OF SURVIVAL RESPONSE IN HORMONE-REFRACTORY PROSTATE-CANCER PATIENTS TREATED WITH SURAMIN
Authors: SRIDHARA R EISENBERGER MA SINIBALDI VJ REYNO LM EGORIN MJ
Citation: R. Sridhara et al., EVALUATION OF BIOMARKERS OF SURVIVAL RESPONSE IN HORMONE-REFRACTORY PROSTATE-CANCER PATIENTS TREATED WITH SURAMIN, Cancer epidemiology, biomarkers & prevention, 7(7), 1998, pp. 631-634
BILATERAL ORCHIECTOMY WITH OR WITHOUT FLUTAMIDE FOR METASTATIC PROSTATE-CANCER
Authors: EISENBERGER MA BLUMENSTEIN BA CRAWFORD ED MILLER G MCLEOD DG LOEHRER PJ WILDING G SEARS K CULKIN DJ THOMPSON IM BUESCHEN AJ LOWE BA
Citation: Ma. Eisenberger et al., BILATERAL ORCHIECTOMY WITH OR WITHOUT FLUTAMIDE FOR METASTATIC PROSTATE-CANCER, The New England journal of medicine, 339(15), 1998, pp. 1036-1042
HARVEST OF INTACT PROSTATE-CANCER CELLS FROM BLOOD FURTHER CHARACTERIZATION OF A NEW ASSAY
Authors: POLASCIK TJ WANG ZP DI SJ GURGANUS RT HORTOPAN SC EISENBERGER MA CARDUCCI MA TSO POP PARTIN AW
Citation: Tj. Polascik et al., HARVEST OF INTACT PROSTATE-CANCER CELLS FROM BLOOD FURTHER CHARACTERIZATION OF A NEW ASSAY, The Journal of urology, 159(5), 1998, pp. 25-25
ASSESSMENT OF HORMONE-REFRACTORY PROSTATE-CANCER
Authors: NEWLING D FOSSA SD ANDERSSON L ABRAHAMSSON PA ASO Y EISENBERGER MA KHOURY S KOZLOWSKI JS KELLY K SCHER H HARTLEYASP B
Citation: D. Newling et al., ASSESSMENT OF HORMONE-REFRACTORY PROSTATE-CANCER, Urology, 49(4A), 1997, pp. 46-53
HOW MUCH CAN WE RELY ON THE LEVEL OF PROSTATE-SPECIFIC ANTIGEN AS AN END-POINT FOR EVALUATION OF CLINICAL-TRIALS - A WORD OF CAUTION
Authors: EISENBERGER MA NELSON WG
Citation: Ma. Eisenberger et Wg. Nelson, HOW MUCH CAN WE RELY ON THE LEVEL OF PROSTATE-SPECIFIC ANTIGEN AS AN END-POINT FOR EVALUATION OF CLINICAL-TRIALS - A WORD OF CAUTION, Journal of the National Cancer Institute, 88(12), 1996, pp. 779-781
PHASE-II EVALUATION OF IFOSFAMIDE MESNA IN METASTATIC PROSTATE-CANCER- A SOUTHWEST-ONCOLOGY-GROUP STUDY/
Authors: WILLIAMSON SK WOLF MK EISENBERGER MA OROURKE MA BRANNON W CRAWFORD ED
Citation: Sk. Williamson et al., PHASE-II EVALUATION OF IFOSFAMIDE MESNA IN METASTATIC PROSTATE-CANCER- A SOUTHWEST-ONCOLOGY-GROUP STUDY/, American journal of clinical oncology, 19(4), 1996, pp. 368-370
PROSTATE-CANCER TREATMENT STRATEGIES BASED ON TUMOR-SPECIFIC BIOLOGICAL PRINCIPLES - FUTURE-DIRECTIONS
Authors: CARDUCCI MA DEWEESE TL NELSON WG SIMONS JW SINIBALDI V EISENBERGER MA
Citation: Ma. Carducci et al., PROSTATE-CANCER TREATMENT STRATEGIES BASED ON TUMOR-SPECIFIC BIOLOGICAL PRINCIPLES - FUTURE-DIRECTIONS, Seminars in oncology, 23(6), 1996, pp. 56-62
SERUM PROSTATE-SPECIFIC ANTIGEN AND DIGITAL RECTAL EXAMINATION FOR EARLY DETECTION OF PROSTATE-CANCER IN A NATIONAL COMMUNITY-BASED PROGRAM
Authors: CRAWFORD ED DEANTONI EP ETZIONI R SCHAEFER VC OLSON RM ROSS CA BLUM DS BERGER ER EISENBERGER MA MCLEOD DG GAMBERT SR STAGGERS FM STONE NN
Citation: Ed. Crawford et al., SERUM PROSTATE-SPECIFIC ANTIGEN AND DIGITAL RECTAL EXAMINATION FOR EARLY DETECTION OF PROSTATE-CANCER IN A NATIONAL COMMUNITY-BASED PROGRAM, Urology, 47(6), 1996, pp. 863-869
A PROSPECTIVE-STUDY OF SURAMIN-INDUCED PERIPHERAL NEUROPATHY
Authors: CHAUDHRY V EISENBERGER MA SINIBALDI VJ SHEIKH K GRIFFIN JW CORNBLATH DR
Citation: V. Chaudhry et al., A PROSPECTIVE-STUDY OF SURAMIN-INDUCED PERIPHERAL NEUROPATHY, Brain, 119, 1996, pp. 2039-2052
OCULAR SYMPTOMS AND SIGNS ASSOCIATED WITH SURAMIN SODIUM TREATMENT FOR METASTATIC CANCER OF THE PROSTATE
Authors: HEMADY RK SINIBALDI VJ EISENBERGER MA
Citation: Rk. Hemady et al., OCULAR SYMPTOMS AND SIGNS ASSOCIATED WITH SURAMIN SODIUM TREATMENT FOR METASTATIC CANCER OF THE PROSTATE, American journal of ophthalmology, 121(3), 1996, pp. 291-296
SOUTHWEST-ONCOLOGY-GROUP STRATEGIES IN PROSTATIC-CARCINOMA
Authors: CRAWFORD ED HUSSAIN M DEANTONI EP THOMPSON IM EISENBERGER MA BLUMENSTEIN B COLTMAN CA
Citation: Ed. Crawford et al., SOUTHWEST-ONCOLOGY-GROUP STRATEGIES IN PROSTATIC-CARCINOMA, Seminars in surgical oncology, 11(1), 1995, pp. 60-64
IDENTIFICATION OF ENDOTHELIN-1 IN THE PATHOPHYSIOLOGY OF METASTATIC ADENOCARCINOMA OF THE PROSTATE
Authors: NELSON JB HEDICAN SP GEORGE DJ REDDI AH PIANTADOSI S EISENBERGER MA SIMONS JW
Citation: Jb. Nelson et al., IDENTIFICATION OF ENDOTHELIN-1 IN THE PATHOPHYSIOLOGY OF METASTATIC ADENOCARCINOMA OF THE PROSTATE, Nature medicine, 1(9), 1995, pp. 944-949
PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMENOF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER
Authors: EISENBERGER MA SINIBALDI VJ REYNO LM SRIDHARA R JODRELL DI ZUHOWSKI EG TKACZUK KH LOWITT MH HEMADY RK JACOBS SC VANECHO D EGORIN MJ
Citation: Ma. Eisenberger et al., PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMENOF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2174-2186
DEVELOPMENT AND VALIDATION OF A PHARMACOKINETICALLY BASED FIXED DOSING SCHEME FOR SURAMIN
Authors: REYNO LM EGORIN MJ EISENBERGER MA SINIBALDI VJ ZUHOWSKI EG SRIDHARA R
Citation: Lm. Reyno et al., DEVELOPMENT AND VALIDATION OF A PHARMACOKINETICALLY BASED FIXED DOSING SCHEME FOR SURAMIN, Journal of clinical oncology, 13(9), 1995, pp. 2187-2195
EVALUATION OF PROSTATE-SPECIFIC ANTIGEN AS A SURROGATE MARKER FOR RESPONSE OF HORMONE-REFRACTORY PROSTATE-CANCER TO SURAMIN THERAPY
Authors: SRIDHARA R EISENBERGER MA SINIBALDI VJ REYNO LM EGORIN MJ
Citation: R. Sridhara et al., EVALUATION OF PROSTATE-SPECIFIC ANTIGEN AS A SURROGATE MARKER FOR RESPONSE OF HORMONE-REFRACTORY PROSTATE-CANCER TO SURAMIN THERAPY, Journal of clinical oncology, 13(12), 1995, pp. 2944-2953
SURAMIN-INDUCED PERIPHERAL NEUROPATHY - CLINICAL AND ELECTROPHYSIOLOGICAL FEATURES
Authors: CHAUDHRY V EISENBERGER MA CORNBLATH DR
Citation: V. Chaudhry et al., SURAMIN-INDUCED PERIPHERAL NEUROPATHY - CLINICAL AND ELECTROPHYSIOLOGICAL FEATURES, Annals of neurology, 38(2), 1995, pp. 337-338
PHASE-II EVALUATION OF DIDEMNIN-B IN HORMONALLY REFRACTORY METASTATICPROSTATE-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: WILLIAMSON SK WOLF MK EISENBERGER MA OROURKE M BRANNON W CRAWFORD ED
Citation: Sk. Williamson et al., PHASE-II EVALUATION OF DIDEMNIN-B IN HORMONALLY REFRACTORY METASTATICPROSTATE-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 13(2), 1995, pp. 167-170
INTERLEUKIN-6 - A CANDIDATE MEDIATOR OF HUMAN PROSTATE-CANCER MORBIDLTY
Authors: TWILLIE DA EISENBERGER MA CARDUCCI MA HSEIH WS KIM WY SIMONS JW
Citation: Da. Twillie et al., INTERLEUKIN-6 - A CANDIDATE MEDIATOR OF HUMAN PROSTATE-CANCER MORBIDLTY, Urology, 45(3), 1995, pp. 542-549
THE EXPERIENCE WITH SURAMIN IN ADVANCED PROSTATE-CANCER
Authors: EISENBERGER MA REYNO L SINIBALDI V SRIDHARA R CARDUCCI M EGORIN M
Citation: Ma. Eisenberger et al., THE EXPERIENCE WITH SURAMIN IN ADVANCED PROSTATE-CANCER, Cancer, 75(7), 1995, pp. 1927-1934
SURAMIN, AN ACTIVE-DRUG FOR PROSTATE-CANCER - INTERIM OBSERVATIONS INA PHASE-I TRIAL (VOL 85, PG 611, 1993)
Authors: EISENBERGER MA REYNO LM JODRELL DI
Citation: Ma. Eisenberger et al., SURAMIN, AN ACTIVE-DRUG FOR PROSTATE-CANCER - INTERIM OBSERVATIONS INA PHASE-I TRIAL (VOL 85, PG 611, 1993), Journal of the National Cancer Institute, 86(8), 1994, pp. 639-640
SURAMIN - DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND ITS USE WITH INTERMITTENT SHORT INFUSIONS TO CONTROL PLASMA DRUG CONCENTRATION IN PATIENTS WITH PROSTATE-CANCER
Authors: JODRELL DI REYNO LM SRIDHARA R EISENBERGER MA TKACZUK KH ZUHOWSKI EG SINIBALDI VJ NOVAK MJ EGORIN MJ
Citation: Di. Jodrell et al., SURAMIN - DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND ITS USE WITH INTERMITTENT SHORT INFUSIONS TO CONTROL PLASMA DRUG CONCENTRATION IN PATIENTS WITH PROSTATE-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 166-175
SURAMIN
Authors: EISENBERGER MA REYNO LM
Citation: Ma. Eisenberger et Lm. Reyno, SURAMIN, Cancer treatment reviews, 20(3), 1994, pp. 259-273
PROGNOSTIC FACTORS IN STAGE D-2 PROSTATE-CANCER - IMPORTANT IMPLICATIONS FOR FUTURE TRIALS - RESULTS OF A COOPERATIVE INTERGROUP STUDY (INT.0036)
Authors: EISENBERGER MA CRAWFORD ED WOLF M BLUMENSTEIN B MCLEOD DG BENSON R DORR FA BENSON M SPAULDING JT
Citation: Ma. Eisenberger et al., PROGNOSTIC FACTORS IN STAGE D-2 PROSTATE-CANCER - IMPORTANT IMPLICATIONS FOR FUTURE TRIALS - RESULTS OF A COOPERATIVE INTERGROUP STUDY (INT.0036), Seminars in oncology, 21(5), 1994, pp. 613-619
SCREENING FOR PROSTATE-CANCER BY DIGITAL RECTAL EXAMINATION AND PROSTATE-SPECIFIC ANTIGEN - RESULTS OF PROSTATE-CANCER AWARENESS WEEK, 1989-1992
Authors: STONE NN DEANTONI EP CRAWFORD ED STAGGERS FM BLUM DS BERGER ER EISENBERGER MA GAMBERT SR
Citation: Nn. Stone et al., SCREENING FOR PROSTATE-CANCER BY DIGITAL RECTAL EXAMINATION AND PROSTATE-SPECIFIC ANTIGEN - RESULTS OF PROSTATE-CANCER AWARENESS WEEK, 1989-1992, Urology, 44(6A), 1994, pp. 18-25
PROSTATE-CANCER AWARENESS WEEK, 1992 - A SUMMARY OF KEY FINDINGS
Authors: DEANTONI E CRAWFORD ED STONE NN BLUM DS BERGER ER EISENBERGER MA GAMBERT SR STAGGERS F
Citation: E. Deantoni et al., PROSTATE-CANCER AWARENESS WEEK, 1992 - A SUMMARY OF KEY FINDINGS, Clinical and investigative medicine, 16(6), 1993, pp. 448-457
Risultati: 1-25 | 26-26